[Comparison of Short-term Efficacy of Neoadjuvant Immunotherapy Combined with Chemotherapy and Surgery Alone for Locally Advanced Resectable Non-small Cell Lung Cancer].
Haitian LiQing LiuBin LiYuzhen ChenJunping LinYuqi MengHaiming FengZhizhong ZhengYiming HuiPublished in: Zhongguo fei ai za zhi = Chinese journal of lung cancer (2024)
Neoadjuvant immunochemotherapy shows promising efficacy in locally advanced resectable NSCLC, with manageable treatment-related adverse events. It is a safe and feasible neoadjuvant treatment modality for locally advanced resectable NSCLC.
Keyphrases
- locally advanced
- rectal cancer
- neoadjuvant chemotherapy
- squamous cell carcinoma
- phase ii study
- radiation therapy
- small cell lung cancer
- minimally invasive
- lymph node
- advanced non small cell lung cancer
- study protocol
- coronary artery disease
- clinical trial
- combination therapy
- open label
- atrial fibrillation
- brain metastases
- tyrosine kinase
- smoking cessation